Lantheus Holdings, Inc. Interest Revenue (Expense), Net
Lantheus Holdings, Inc. (LNTH) reported Interest Revenue (Expense), Net of -$5.42 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InterestRevenueExpenseNet · last filed 2017-05-02
- Lantheus Holdings, Inc. interest revenue (expense), net for the quarter ending 2017-03-31 was -$5.42M.
- Lantheus Holdings, Inc. interest revenue (expense), net for the quarter ending 2016-12-31 was -$5.84M.
- Lantheus Holdings, Inc. interest revenue (expense), net for the quarter ending 2016-09-30 was -$6.79M.
- Lantheus Holdings, Inc. interest revenue (expense), net for the quarter ending 2016-06-30 was -$6.98M.
- Lantheus Holdings, Inc. interest revenue (expense), net for fiscal 2016 was -$26.62M.
- Lantheus Holdings, Inc. interest revenue (expense), net for fiscal 2015 was -$38.72M.
- Lantheus Holdings, Inc. interest revenue (expense), net for fiscal 2014 was -$42.29M.
| Period end | Interest Revenue (Expense), Net 3 month | Interest Revenue (Expense), Net 3 month as first filed | Interest Revenue (Expense), Net 6 month | Interest Revenue (Expense), Net 9 month | Interest Revenue (Expense), Net 12 month |
|---|---|---|---|---|---|
| 2017-03-31 | -$5.42M 10-Q · filed 2017-05-02 | -$11.26M derived: sum of 2 quarters · filed 2017-05-02 | -$18.04M derived: sum of 3 quarters · filed 2017-05-02 | -$25.02M derived: sum of 4 quarters · filed 2017-05-02 | |
| 2016-12-31 | -$5.84M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$12.62M derived: sum of 2 quarters · filed 2017-02-23 | -$19.60M derived: sum of 3 quarters · filed 2017-02-23 | -$26.62M 10-K · filed 2017-02-23 | |
| 2016-09-30 | -$6.79M 10-Q · filed 2016-11-01 | -$13.76M derived: sum of 2 quarters · filed 2016-11-01 | -$20.78M 10-Q · filed 2016-11-01 | -$27.90M derived: sum of 4 quarters · filed 2017-05-02 | |
| 2016-06-30 | -$6.98M 10-Q · filed 2016-08-04 | -$14.00M 10-Q · filed 2016-08-04 | -$21.12M derived: sum of 3 quarters · filed 2017-05-02 | -$28.22M derived: sum of 4 quarters · filed 2017-05-02 | |
| 2016-03-31 | -$7.02M 10-Q · filed 2017-05-02 | -$7.02M 10-Q · filed 2016-05-03 | -$14.14M derived: sum of 2 quarters · filed 2017-05-02 | -$21.24M derived: sum of 3 quarters · filed 2017-05-02 | -$35.12M derived: sum of 4 quarters · filed 2017-05-02 |
| 2015-12-31 | -$7.12M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$14.22M derived: sum of 2 quarters · filed 2017-02-23 | -$28.09M derived: sum of 3 quarters · filed 2017-02-23 | -$38.72M 10-K · filed 2017-02-23 | |
| 2015-09-30 | -$7.10M 10-Q · filed 2016-11-01 | -$20.98M derived: sum of 2 quarters · filed 2016-11-01 | -$31.60M 10-Q · filed 2016-11-01 | -$42.18M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-06-30 | -$13.88M 10-Q · filed 2016-08-04 | -$24.50M 10-Q · filed 2016-08-04 | -$35.08M derived: sum of 3 quarters · filed 2017-02-23 | -$45.67M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-03-31 | -$10.62M 10-Q · filed 2016-05-03 | -$21.21M derived: sum of 2 quarters · filed 2017-02-23 | -$31.79M derived: sum of 3 quarters · filed 2017-02-23 | -$42.36M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2014-12-31 | -$10.58M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$21.17M derived: sum of 2 quarters · filed 2017-02-23 | -$31.74M derived: sum of 3 quarters · filed 2017-02-23 | -$42.29M 10-K · filed 2017-02-23 | |
| 2014-09-30 | -$10.59M 10-Q · filed 2015-11-04 | -$21.15M derived: sum of 2 quarters · filed 2015-11-04 | -$31.70M 10-Q · filed 2015-11-04 | ||
| 2014-06-30 | -$10.57M 10-Q · filed 2015-08-05 | -$21.12M 10-Q · filed 2015-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |